hypertension
FDA approves Idorsia’s Tryvio for treatment of high blood pressure
March 22, 2024Medical Communications Cardiology, FDA, Tryvio, blood pressure, blood presure, hypertension
Idorsia has announced that the US Food and Drug Administration (FDA) has approved Tryvio (aprocitentan) for the treatment of hypertension …
Alnylam and Roche partner for RNAi therapeutic for treatment of hypertension
July 24, 2023Research and Development Alnylam, Cardiology, Roche, hypertension, rnai, zilebesiran
Alnylam Pharmaceuticals has announced that it has entered a strategic agreement with Roche for the development and commercialisation of zilebesiran, …
United Therapeutics buys Arena’s hypertension drug ralinepag in deal worth $1.2 billion
November 16, 2018Medical Communications Arena, PAH, United Therapeutics, deal sales, hypertension
US pharma firm United Therapeutics has agreed to by Arena Pharmaceuticals experimental pulmonary arterial hypertension (PAH) drug ralinepag in a …
Kitov’s combo gets FDA approval in osteoarthritis and hypertension
June 1, 2018Medical Communications, Sales and Marketing Consensi, FDA, Kitov, US, hypertension, osteoarthritis, pharma
Israeli biopharmaceutical firm is celebrating the approval in the US of Consensi, a combo of the calcium channel blocker amlodipine …
Glenmark greenlighted to market hypertension generic in US
May 30, 2017Manufacturing and Production, Sales and Marketing FDA, Glenmark, generic, hypertension
Glenmark Pharmaceuticals has revealed it has been awarded final approval by the FDA to market hypertension treatment nebivolol, a generic …
FDA approves Allergan hypertension fixed-dose combo, Byvalson
June 7, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, FDA, US, angiotensin ii, approval, beta blocker, byvalson, hypertension, nebivolol, valsartan
Allergan has announced that the US Food and Drug Administration (FDA) has approved its fixed-dose combination, Byvalson (nebivolol and valsartan), …
Actelion granted EU approval for hypertension treatment
May 17, 2016Manufacturing and Production, Sales and Marketing Actelion, Uptravi, eu approval, hypertension
Actelion Pharmaceuticals has received marketing authorisation from the European Commission for Uptravi (selexipag) for the long-term treatment of patients with …
Mylan launches new dosages of generic of Novartis hypertension drug in US
April 11, 2016Manufacturing and Production Mylan, Novartis, generic, high blood pressure, hypertension
Mylan (TASE: MYL) has announced the US launch of new dosages of its generic version of Novartis’s hypertension drug, Lopressor …
Bayer pill gains FDA approval despite shutdown
October 9, 2013Sales and Marketing Bayer, FDA, adempas, hypertension
In the midst of the US shutdown of government agencies the FDA has managed to approve Bayer’s Adempas for patients …
Takeda’s blood pressure treatment Edarbi approved
December 9, 2011Sales and Marketing Diovan, Eisai, cardiovascular, high blood pressure, hypertension
Takeda’s new hypertension treatment Edarbi has been approved in Europe.Edarbi (azilsartan medoxomil) is a new once-daily angiotensin receptor blocker (ARB) …
BMS and Sanofi recall 64 million Avalide tablets
January 18, 2011Manufacturing and Production Avalide, Avapro, Bristol-Myers Squibb, GMP, Good Manufacturing Practice, Sanofi-Aventis, hypertension, irbesartan
Bristol-Myers Squibb and Sanofi-Aventis have started another massive recall of their antihypertensive product Avalide because a manufacturing defect could affect …
New global ‘polypill’ trials start
May 17, 2010Research and Development Dr Reddy, hypertension, polypill, statin
New trials of a daily polypill – combining aspirin, a statin and two blood pressure lowering medicines – are underway …
Tekturna fails to show heart attack benefit
March 17, 2010Research and Development Diovan, Novartis, Tekturna, hypertension
Novartis’ hypertension treatment Tekturna has failed to show it helps patients recover from a heart attack when added to standard …
Conventional hypertension prescribing ‘should be reconsidered’
March 16, 2010NICE, hypertension
New findings throwing doubt on conventional wisdom about high blood pressure may have implications for NICE’s advice on hypertension. Published …
Triple approval for Novartis in Japan
January 20, 2010Sales and Marketing Afinitor, Asia, Exforge, Galvus, Japan, Novartis, hypertension
Japanese regulators have approved three new Novartis medicines for use patients with type II diabetes, high blood pressure and advanced …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
